Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2024

Aug 30, 2024

61176_rns_2024-08-30_297a895e-e340-46d4-ab03-877f7b6955ab.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

BIO/SECL/SP/2024-25/81

August 30, 2024

To,
The Secretary
BSE Limited
Department of Corporate Services
Phiroze Jeejeebhoy Towers,
Dalal Street,Mumbai – 400 001
To,
The Secretary
National Stock Exchange of India Limited
Corporate Communication Department
Exchange Plaza, Bandra Kurla Complex
Mumbai – 400 050
Scrip Code - 532523 Scrip Symbol - BIOCON

Dear Sir/ Madam,

Subject: Intimation regarding Credit Rating

Pursuant to under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has received rating letters dated August 30, 2024, from ICRA Limited (ICRA) with the following affirmation in the credit rating w.r.t. below mentioned instruments:

Sl. No. Instruments Rated Amount
(Rs. In Crores)
Rating Action
1 Long-term term loans 205.00 [ICRA]AA+(Stable);Reaffirmed
2 Long-term/ Short-term fund based/
non-fund based
245.00 [ICRA]AA+(Stable)/ [ICRA]A1+;
Reaffirmed
3 Commercial Paper Programme (CP) 0.00 [ICRA]A1+; reaffirmed and
withdrawn

The rating letters received in this regard are enclosed as Annexure – A & B.

The above information will also be available on the website of the Company at www.biocon.com.

Kindly take the same on record and acknowledge.

Thanking You,

Yours faithfully,

For Biocon Limited

MAYANK Digitally signed by MAYANK VERMA VERMA Date: 2024.08.30 18:50:22 +05'30'


Mayank Verma Company Secretary and Compliance Officer Membership No.: ACS 18776

Encl.: Rating Letters from ICRA

==> picture [115 x 54] intentionally omitted <==

ICRA Limited

Ref: ICRA/Biocon Limited/30082024/01

Date: August 30, 2024

Mr. Mukesh Kamath

Interim Chief Financial Officer

Biocon Limited

20[th] KM, Hosur Road Electronics City Bengaluru 560100, Karnataka, India.

Dear Sir,

Re: ICRA’s Credit Rating for below mentioned Instruments of Biocon Limited

As per the Rating Agreement/Statement of Work executed with ICRA Limited, ICRA’s Rating Committee has taken the following rating actions for the mentioned instruments of your company.

Instrument Rated Amount Rating Action1
(Rs. crore)
Long-term term loans 205.00 [ICRA]AA+(Stable); Reaffirmed
Long-term/ Short-term fund-
based/ non-fund based
245.00 [ICRA]AA+(Stable)/ [ICRA]A1+;
Reaffirmed
Total 450.00

The aforesaid ratings will become due for surveillance within one year from the date of rating communication letter. However, ICRA reserves the right to review and/or, revise the above rating(s) at any time based on new information becoming available, or the required information not being available, or other circumstances that ICRA believes could have an impact on the rating(s). Therefore, request the lenders and investors to visit ICRA website at www.icra.in for latest rating(s) of the company.

The ratings are specific to the terms and conditions of the instruments as indicated to us by you, and any change in the terms or size of the same would require a review of the rating(s) by us. In case there is any change in the terms and conditions or the size of the rated instrument, the same must be brought to our notice before the instrument is used by you. In the event such changes occur after the rating(s) have been assigned by us and their use has been confirmed by you, the rating(s) would be subject to our review, following which there could be a change in the rating(s) previously assigned. Notwithstanding the foregoing, any change in the over-all limit of the instrument from that specified in this letter, would constitute an enhancement that would not be covered by or under the said Rating Agreement.

The rating(s) assigned must be understood solely as an opinion and should not be treated, or cause to be treated, as recommendation to buy, sell, or hold the rated instrument availed/issued by your company.

You are also requested to forthwith inform us about any default or delay in repayment of interest or principal amount of the instrument rated, as above, or any other debt instruments/ borrowing and keep us informed of any other developments which may have a direct or indirect impact on the debt servicing capability of the company including any proposal for re-schedulement or postponement of the repayment programmes of the dues/ debts of the company with any lender(s) / investor(s), or occurrence of any significant development

1 Complete definitions of the ratings assigned are available at www.icra.in.

Building No. 8, 2[nd] Floor, Tower A DLF Cyber City, Phase II Gurugram – 122002, Haryana

Tel.: +91.124 .4545300 CIN: L749999DL1991PLC042749

Website: www.icra.in Email: [email protected] Helpdesk: +91 9354738909

Registered Office: B-710, Statesman House, 148, Barakhamba Road, New Delhi 110001. Tel.: +91.11.23357940-41

R A T I N G ● R E S E A R C H ● I N F O R M A T I O N

==> picture [115 x 55] intentionally omitted <==

that could impact the ability of the company to raise funds such as restriction imposed by any authority from raising funds through issuance of debt securities through electronic bidding system. Further, you are requested to inform us immediately as and when the borrowing limit for the instrument rated, as above, or as prescribed by the regulatory authority(ies) is exceeded.

We look forward to your communication and assure you of our best services.

With kind regards, Yours sincerely, For ICRA Limited

Suprio Banerjee Vice President [email protected]

==> picture [115 x 55] intentionally omitted <==

Annexure

Annexure
Details of Bank Limits Rated by ICRA (on
long term scale)
Amount Rating Rating Assigned on
Term Loans
HDFC Limited* 205.00 [ICRA]AA+(Stable) August 23, 2024
Details of Bank Limits Rated by ICRA (on
long term/short term scale)
Amount Rating Rating Assigned on
Details of Bank Limits Rated by ICRA (on
**long term scale/ short term scale)# **
Proposed limits 245.00 [ICRA]AA+(Stable)/
[ICRA]A1+
August 23, 2024
Total 450.00
  • In the form of External Commercial Borrowings

LT rating of [ICRA]AA+ or ST rating of [ICRA]A1+ will apply depending on the tenure of the facility availed

==> picture [115 x 54] intentionally omitted <==

ICRA Limited

ICRA/ Biocon Limited/ 30082024/02

Date: August 30, 2024

Mr. Mukesh Kamath

Interim Chief Financial Officer Biocon Limited 20[th] KM, Hosur Road Electronics City Bengaluru 560100, Karnataka, India.

Dear Sir,

Re: ICRA’s Credit Rating for below mentioned Instruments of Biocon Limited

In accordance with the requirements of ICRA’s policy on withdrawal, ICRA’s Rating Committee has taken the following rating action:

Instrument Rated Amount Rating Action1
(Rs. crore)
Commercial Paper Programme
(CP)
0.00 [ICRA]A1+; reaffirmed and withdrawn
Total 0.00

The press release for withdrawal of the rating is enclosed for your reference. We look forward to your communication and assure you of our best services.

With kind regards, Yours sincerely, For ICRA Limited

Suprio Banerjee Vice President [email protected]

1 Complete definitions of the ratings assigned are available at www.icra.in.

Building No. 8, 2[nd] Floor, Tower A DLF Cyber City, Phase II Gurugram – 122002, Haryana

Tel.: +91.124 .4545300 CIN: L749999DL1991PLC042749

Website: www.icra.in Email: [email protected] Helpdesk: +91 9354738909

Registered Office: B-710, Statesman House, 148, Barakhamba Road, New Delhi 110001. Tel.: +91.11.23357940-41

R A T I N G ● R E S E A R C H ● I N F O R M A T I O N